A serious brain injury can change much more than a person’s ability to move.
It can also damage the brain pathways needed to speak clearly and swallow safely, making conversation, eating and everyday independence much harder.
Researchers at the University of Pittsburgh School of Medicine have now found early evidence that carefully tuned electrical stimulation deep inside the brain may help.
Their proof-of-concept study was published on July 18, 2026, in Nature Communications.
The treatment is called deep brain stimulation, or DBS.
It uses thin electrodes placed in specific areas of the brain to deliver small electrical pulses, and it is already used for some movement disorders, including tremor and Parkinson’s disease.
The Pitt team focused on a deep brain area called the motor thalamus. This region communicates with parts of the brain that control movement, including movements of the lips, tongue, jaw, throat and other muscles needed for speech and swallowing.
Speech is surprisingly complicated. To say even a simple sentence, the brain must coordinate breathing, the voice box, the tongue, lips and facial muscles with precise timing, while swallowing requires another carefully ordered series of movements to move food and liquid safely toward the stomach.
Traumatic brain injury can interrupt the nerve pathways carrying these commands. Some people develop dysarthria, meaning their speech becomes weak, slow or difficult to understand, while others develop dysphagia, which makes swallowing difficult and can increase the risk that food or liquid enters the airway.
Standard rehabilitation can help, especially therapy with speech-language professionals. However, recovery varies widely, and communication devices can help people express themselves without actually restoring the natural muscle control required for speech.
The researchers wondered whether DBS could strengthen brain signals traveling through nerve pathways that survived an injury. Their earlier work suggested that low-frequency stimulation of the motor thalamus could improve arm and hand movement after traumatic brain injury.
Frequency turned out to be especially important. Conventional DBS often uses stimulation around 130 hertz, but high-frequency stimulation can sometimes worsen speech, so the researchers tested much lower frequencies between 50 and 80 hertz.
First, they studied eight people who were already having DBS electrodes implanted to treat essential tremor and whose speech and swallowing pathways were intact. Low-frequency stimulation increased activity in facial and throat muscles involved in speaking and swallowing without noticeably damaging normal speech.
The researchers then studied one person who had experienced a traumatic brain injury and was living with severe speech difficulty and moderate swallowing problems. When low-frequency stimulation was switched on, the participant showed stronger and faster facial movements as well as improvements in swallowing and several parts of speech production.
The clearest result involved how understandable his words were. Across three testing sessions, word intelligibility improved by 8%, 20% and 16% when stimulation was on compared with when it was off.
Those changes are potentially meaningful because the researchers note that an improvement of about 7% can represent a small clinically important change, while roughly 15% can represent a large one. The effects also appeared quickly, supporting the idea that stimulation was helping remaining brain pathways carry stronger movement signals.
The study offers an intriguing new direction, but it should be interpreted cautiously. Only one participant with traumatic brain injury was tested for the key speech and swallowing outcomes, so the results cannot yet show that DBS will work for most people with similar injuries.
DBS also requires brain surgery and is not a simple rehabilitation tool. Larger clinical studies will need to determine who might benefit, how long improvements last, what stimulation settings work best and whether the possible gains outweigh the risks of an implanted device.
Even with those limitations, the research is important because it challenges the idea that DBS necessarily harms speech. It suggests that the effect may depend strongly on how the stimulation is delivered, with lower frequencies potentially helping damaged motor pathways rather than suppressing them.
The Pitt researchers are now investigating whether repeated stimulation can produce longer-lasting gains in speech and in hand and arm function. A clinical trial is testing stimulation over four weeks, which should provide stronger evidence about whether the immediate improvements seen in this early work can become useful rehabilitation benefits.
Overall, the findings are promising rather than definitive. They provide a biological explanation and an encouraging human example, but much larger studies are needed before low-frequency motor thalamus DBS could be considered an established treatment for speech or swallowing problems after brain injury.
